CymaBay Therapeutics Q3 EPS $(0.38) Misses $(0.37) Estimate

CymaBay Therapeutics (NASDAQ:CBAY) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.37) by 2.7 percent. This is a 11.76 percent decrease over losses of $(0.34) per share

Benzinga · 11/05/2019 21:36

CymaBay Therapeutics (NASDAQ:CBAY) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.37) by 2.7 percent. This is a 11.76 percent decrease over losses of $(0.34) per share from the same period last year.